'Signposts on the journey'; medication adherence and the lived body in men with Parkinson's disease

被引:14
作者
Gibson, Grant [1 ]
机构
[1] Univ Stirling, Sch Appl Social Sci, Colin Bell Bldg, Stirling FK9 4LA, Scotland
关键词
UK; Parkinson's disease; Lived body; Embodiment; Medication; Adherence; OLDER-ADULTS; EXPERIENCE; MEDICINE;
D O I
10.1016/j.socscimed.2016.01.023
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Adherence to medication has been identified as a key issue in the treatment of many chronic illnesses, however such a perspective fails to account for the lived experience of medication usage and its effects on the body as lived. Parkinson's Disease, a neurological disease predominantly affecting movement and mobility, and which is treated via a wide range of medications provides a useful opportunity to explore experiences of medication usage in chronic illness. Reporting on findings of a study exploring men's experience of living with Parkinson's Disease, this paper adopts a lived body perspective to explore lived experiences of medication usage and adherence in PD. Findings are reported from 30 narrative in depth interviews with 15 men of various ages living with Parkinson's disease of mild to severe intensity. Findings first discuss PD's effects on men's sense of the lived body, in which a fluctuating embodiment is linked to medication regimes and their bodily effects. Second, as PD disrupts the body's place with the everyday and habitual experience of lived time, medication regimens come to place new structures upon the men's everyday experience of time. Finally, the paper explores the role medications play in men's attempts to create and sustain narratives for the individual progression of their illness, and how these narratives differ from clinical narratives associated with PD's treatment. This paper concludes by discussing debates around adherence to medication within the treatment of PD and the need to consider lived experience of medication usage and their effects at the level of the lived body. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
[31]   The effect of a structured medication review on quality of life in Parkinson's disease: The study protocol [J].
Oonk, N. G. M. ;
Movig, K. L. L. ;
Munster, E. M. ;
Koehorst-Ter Huurne, K. ;
van der Palen, J. ;
Dorresteijn, L. D. A. .
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 13
[32]   Adherence to istradefylline in patients with Parkinson's disease: A group-based trajectory analysis [J].
Fukasawa, Toshiki ;
Nakanishi, Etsuro ;
Shimoda, Hiroo ;
Shinoda, Katsumi ;
Ito, Satoru ;
Asada, Shinji ;
Yoshida, Satomi ;
Tanaka-Mizuno, Sachiko ;
Mizuno, Kayoko ;
Takahashi, Ryosuke ;
Kawakami, Koji .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 462
[33]   Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis [J].
Tiao, Darren K. ;
Chan, Webber ;
Jeganathan, Jayson ;
Chan, Jenny T. ;
Perry, Jonathan ;
Selinger, Christian P. ;
Leong, Rupert W. .
INFLAMMATORY BOWEL DISEASES, 2017, 23 (08) :257-261
[34]   Adherence to a strict medication protocol can reduce length of stay in hospitalized patients with Parkinson's Disease [J].
Azmi, Hooman ;
Cocoziello, Lisa ;
Nyirenda, Themba ;
Douglas, Claudia ;
Jacob, Blessy ;
Thomas, Jewell ;
Cricco, Donna ;
Finnerty, Giuseppina ;
Sommer, Kirsten ;
Rocco, Anthony ;
Thomas, Randy ;
Roth, Patrick ;
Thomas, Florian P. .
CLINICAL PARKINSONISM & RELATED DISORDERS, 2020, 3
[35]   Parkinson's Disease: Update on Medication Management [J].
Kriebel-Gasparro, Ann .
JNP-JOURNAL FOR NURSE PRACTITIONERS, 2016, 12 (03) :E81-E89
[36]   Levodopa dosage determines adherence to long-acting dopamine agonists in Parkinson's disease [J].
Santos-Garcia, Diego ;
Prieto-Formoso, Maria ;
de la Fuente-Fernandez, Raul .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 318 (1-2) :90-93
[37]   Medication Management Performance in Parkinson's Disease: Examination of Process Errors [J].
Sumida, Catherine A. ;
Lopez, Francesca, V ;
Van Etten, Emily J. ;
Whiteley, Nicole ;
Moore, Raeanne C. ;
Litvan, Irene ;
Lessig, Stephanie ;
Gilbert, Paul E. ;
Schmitter-Edgecombe, Maureen ;
Filoteo, J. Vincent ;
Schiehser, Dawn M. .
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2021, 36 (07) :1307-1315
[38]   An assessment of Parkinson's disease medication treatment patterns in the Medicaid population [J].
Johnsrud, Michael ;
Richards, Kristin ;
Arcona, Steve ;
Sasane, Rahul ;
Leoni, Matthew .
CLINICAL PARKINSONISM & RELATED DISORDERS, 2021, 5
[39]   Adherence and perception of antiparkinsonic therapy in Mexican patients with Parkinson's disease [J].
Amin, Cervantes-Arriaga ;
Mayela, Rodriguez-Violante ;
Lisette, Bazan-Rodriguez ;
Alejandra, de la Cruz-Landero ;
Azyadeh, Camacho-Ordonez ;
Paulina, Gonzalez-Latapi ;
Salvador, Velazquez-Osuna .
REVISTA MEXICANA DE NEUROCIENCIA, 2014, 15 (01) :11-17
[40]   The Impact ofCOVID-19 on Access to Parkinson's Disease Medication [J].
Cheong, Julia Ling-Yu ;
Goh, Zhao Hang Keith ;
Marras, Connie ;
Tanner, Caroline M. ;
Kasten, Meike ;
Noyce, Alastair J. .
MOVEMENT DISORDERS, 2020, 35 (12) :2129-2133